JPRN-jRCTs011190012
Recruiting
Phase 2
Prophylaxis of postoperative atrial fibrillation by L-Carnitine in heart valve surgery - a randomized controlled trial - PPOAFVALVEtrial
Shingu Yasushige0 sites145 target enrollmentMarch 18, 2020
Overview
- Phase
- Phase 2
- Intervention
- Not specified
- Conditions
- Heart valve disease
- Sponsor
- Shingu Yasushige
- Enrollment
- 145
- Status
- Recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Patients who undergo heart valve surgery
Exclusion Criteria
- •Patients with atrial fibrillation ventricular arrhythmia, unstable angina, acute myocardial infarction, hemodialysis, digitalis, and class I and III antiarrhythmic agents; pregnant women; emergent case
Outcomes
Primary Outcomes
Not specified
Similar Trials
Active, not recruiting
Phase 1
Prevention of post-operative Atrial Fibrillation by BOTulinum toxin injections into epicardial fat pads around pulmonary veins in patients undergoing cardiac surgeryEUCTR2018-002541-11-FRASSISTANCE PUBLIQUE - HOPITAUX DE PARIS (AP-HP)220
Completed
Not Applicable
Prevention of Postoperative Atrial Fibrillation after Heart Valve Surgery by L-Carnitine: Study Protocol for An Observational Intervention StudyHeart valve diseasesJPRN-UMIN000025737Hokkaido University Hospital; Department of Cardiovascular and Thoracic Surgery16
Completed
Not Applicable
Prevention of Post-Operative Atrial FibrillatioPost-operative atrial fibrillationCirculatory SystemAtrial fibrillation and flutterISRCTN45347268Fondo de Desarrollo Científico y Tecnológico (Chile)150
Recruiting
Phase 3
Prevention Atrial Fibrillation by BOTulinum Toxin Injections (BOTAF)Cardiac SurgeryNCT04075981Assistance Publique - Hôpitaux de Paris220
Recruiting
Phase 4
Prevention of complications during atrial fibrillation ablation with the second-generation cryoballooatrial fibrillationcardiac arrhythmia10007521NL-OMON41330eids Universitair Medisch Centrum75